OTCMKTS:PPTDF PeptiDream (PPTDF) Stock Price, News & Analysis $6.57 -0.12 (-1.80%) As of 11/20/2026 11:41 AM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChart About PeptiDream Stock (OTCMKTS:PPTDF) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get PeptiDream alerts:Sign Up Key Stats Today's Range$6.57▼$6.5750-Day Range$6.57▼$7.2952-Week Range$5.88▼$12.85Volume700 shsAverage Volume1,060 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview PeptiDream Inc. is a Japan-based biopharmaceutical company founded in 2006. It discovers and develops peptide-based drug candidates using its proprietary Peptide Discovery Platform System, known as PDPS. The platform is designed to identify peptides, including macrocyclic peptides made with nonstandard amino acids, that can bind to drug targets. PeptiDream applies this technology to its own research programs and collaborates with pharmaceutical and biotechnology companies on drug discovery and development. Based in Kawasaki, Japan, the company works with partners in Japan and internationally. Its founder, Patrick C. Reid, has served as its chief executive officer.AI Generated. May Contain Errors. Read More Receive PPTDF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for PeptiDream and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. PPTDF Stock News HeadlinesPeptiDream’s New Kidney Cancer Trial Adds Radiopharma Upside for PPTDF InvestorsSeptember 18, 2026 | tipranks.comCurium Group, PeptiDream and PDRadiopharma Announce Completion of Patient Dosing in Clinical Trial of 64Cu-PSMA-I&T for Prostate Cancer in JapanJune 11, 2026 | globenewswire.comWorse than socialismDonald Trump and Bernie Sanders rarely agree on anything, yet both are steering the country toward the same economic system, according to veteran analyst Porter Stansberry. The government has already taken stakes in companies like Intel, Lithium Americas, and MP Materials, while political rhetoric on both sides points toward deeper centralization. Stansberry has spent months investigating what this bipartisan shift could mean for investors navigating the months ahead. | Porter & Company (Ad)PeptiDream Announces the Initiation of Phase 1 Clinical Trial by Its Collaboration PartnerApril 20, 2026 | businesswire.comPeptiDream Inc. (PPTDF) Q4 2025 Earnings Call TranscriptFebruary 16, 2026 | seekingalpha.comCurium Group, PeptiDream and PDRadiopharma Enroll First Patient to Registrational Clinical Trial of Lu-PSMA-I&T for Prostate Cancer in JapanFebruary 4, 2026 | globenewswire.comSee More Headlines PPTDF Stock Analysis - Frequently Asked Questions How have PPTDF shares performed this year? PeptiDream's stock was trading at $12.48 at the start of the year. Since then, PPTDF stock has decreased by 47.3% and is now trading at $6.5745. How do I buy shares of PeptiDream? Shares of PPTDF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorHealthcare Industry Biotechnology Sub-IndustryBiotechnology Current SymbolOTCMKTS:PPTDF CIKN/A Webwww.peptidream.com Phone81-4-4270-1300FaxN/AEmployees645Year FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 10 Best Stocks to Own in Fall 2026AI spending is reshaping the market, and the opportunity extends far beyond the biggest chipmakers. Discover 10 stocks set to benefit from powerful trends in AI infrastructure, cloud computing, energy, capital returns, and consumer growth this fall.Get This Free Report This page (OTCMKTS:PPTDF) was last updated on 11/20/2026 by MarketBeat.com Staff. From Our PartnersPrediction: NVDA will “snap back” on this dateOthers paid $500 for the Snapback Indicator. For Black Friday, Base Camp Trading is offering lifetime access f...Base Camp Trading | SponsoredYour $7 scanner is waitingThe Instant Scanner is $7 in Bill Poulos's Black Friday sale. Every night it delivers a list showing which sto...Profits Run | SponsoredThis Gold Pays Up To 15% (Government Can't Touch It)Larry Fink foresees $110 trillion in assets being tokenized, bigger than the entire US stock market. $1.6 bill...Decentralized Masters | SponsoredELON + YOU + DECEMBER 8THElon Musk's next big project may be the most ambitious move of his career, and all signs point to December 8th...Paradigm Press | SponsoredWhat the hell is going on?Porter Stansberry says President Trump is quietly replacing the U.S. dollar without a vote in Congress, and th...Porter & Company | SponsoredFinancial legend: “This is bad, really bad...”Dr. Martin D. Weiss has publicly predicted six major American financial crashes over his 55-year career leadin...Weiss Ratings | SponsoredA New Independent “Federal Reserve” Has Just Emerged in AmericaA new independent Federal Reserve has reportedly been created for America. It could be publicly revealed as...Banyan Hill Publishing | SponsoredNoah’s Ark found?Scientists may have discovered Noah's Ark buried under a mountain in eastern Turkey, just two miles from the I...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PeptiDream Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share PeptiDream With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.